Hypertension is the leading cause of cardiovascular disease in Latin America, affecting between 20-40% of adults and responsible for more than two million deaths annually. Yet despite its devastating impact, awareness and treatment rates remain extremely low across the region, according to a comprehensive 2026 consensus developed by leading health experts from Latin American countries, the USA, and Europe.

Why Is Hypertension So Prevalent in Latin America?

The high rates of high blood pressure in Latin America stem from a complex web of environmental, economic, and social factors that differ significantly from other regions. The consensus identifies several interconnected drivers that make cardiovascular disease prevention particularly challenging in the region.

Beyond hypertension itself, metabolic disturbances compound the problem. Type 2 diabetes, obesity, and metabolic syndrome are widespread across Latin America, creating a cascade of cardiovascular risk. The prevalence of overweight and obesity has surged dramatically over the past four decades: reaching 10-20% in children, 30-40% in adolescence, and 60-70% in adults. These conditions often occur together, amplifying heart disease risk.

The root causes of this epidemic extend beyond individual choices. The consensus identifies key determinants including:

• Environmental Factors: Access to healthy food options, safe spaces for physical activity, and clean water vary dramatically across Latin American countries and within urban versus rural areas.
• Socioeconomic Barriers: Social inequity, low education levels, and limited access to healthcare prevent many people from learning about or affording blood pressure treatment.
• Food Quality: The availability and affordability of processed foods high in sodium and unhealthy fats contribute to hypertension and obesity.
• Genetic Predisposition: The diverse ethnic backgrounds across Latin America influence cardiovascular risk profiles differently than in other populations.
• Behavioral and Political Factors: Cultural attitudes toward health, limited health policy implementation, and contextual behaviors shape disease prevalence.

What Do Current Treatment Rates Reveal About the Problem?

Perhaps the most alarming finding is that many people with hypertension and related metabolic disorders in Latin America don't even know they have the condition. Studies across the region have documented extremely low rates of awareness, treatment, and control of cardiovascular risk factors in the general population. This knowledge gap translates directly into preventable deaths and disability.

The problem is particularly severe among patients with metabolic disorders, who face compounded risks. When hypertension coexists with diabetes, obesity, or metabolic syndrome, the danger of heart attack and stroke increases exponentially. Yet these patients often receive fragmented care or no treatment at all, leading to high cardiovascular morbidity and mortality rates.

How to Improve Hypertension Management in Latin America

The 2026 consensus provides clear recommendations for health professionals to address this crisis. The expert panel developed evidence-based strategies tailored to the Latin American context, incorporating new research since the previous 2019 consensus and lessons learned from the region itself.

• Increase Awareness Campaigns: Public health initiatives must educate communities about hypertension symptoms, risk factors, and the importance of regular blood pressure screening, particularly targeting underserved populations.
• Implement Lifestyle Interventions: Structured programs addressing diet quality, physical activity, weight management, and stress reduction should be integrated into primary care and community health settings.
• Optimize Antihypertensive Drug Therapy: Healthcare providers should use evidence-based drug combinations and treatment protocols to achieve better blood pressure control, with attention to affordability and medication access.
• Address Metabolic Comorbidities: Integrated care approaches must simultaneously manage hypertension, diabetes, obesity, and metabolic syndrome rather than treating each condition in isolation.
• Strengthen Healthcare Infrastructure: Training health professionals across internal medicine, cardiology, nephrology, endocrinology, and other specialties ensures comprehensive, coordinated care delivery.

The consensus was developed by a large group of experts representing multiple disciplines and countries, including specialists in internal medicine, cardiology, nephrology, endocrinology, geriatrics, pediatrics, pharmacology, and epidemiology. This multidisciplinary approach reflects the understanding that hypertension and its associated conditions require coordinated, comprehensive strategies.

The 2026 update aims to provide clear and useful recommendations for health professionals working across Latin America to improve awareness, treatment, and control of hypertension and associated cardiovascular risk factors. By addressing the region's unique social, economic, and environmental challenges, experts hope to reduce the burden of preventable cardiovascular disease and save millions of lives.